keyword
MENU ▼
Read by QxMD icon Read
search

ASCVD

keyword
https://www.readbyqxmd.com/read/29667200/treatment-in-a-preventive-cardiology-clinic-utilizing-advanced-practice-providers-apps-effectively-closes-atherosclerotic-cardiovascular-disease-ascvd-risk-management-gaps-amongst-a-primary-prevention-population-compared-with-a-propensity-matched-primary-care
#1
Emilio Fentanes, Anthony G Vande Hei, R Scott Holuby, Norma Suarez, Yousif Slim, Jennifer N Slim, Ahmad M Slim, Dustin Thomas
BACKGROUND: Advanced Practice Providers (APPs) can fill access to care gaps created by physician shortages and improve adherence/compliance with preventive atherosclerotic cardiovascular disease (ASCVD) interventions. METHODS: We retrospectively reviewed data on 595 patients enrolled in a preventive cardiology clinic (PCC) utilizing APPs compared with a propensity-matched cohort (PMC) of 595 patients enrolled in primary care clinics alone. PCC patients were risk stratified using Framingham risk scoring (FRS) and coronary artery calcium scoring (CACS) and treated based on published guideline-based algorithms...
April 17, 2018: Clinical Cardiology
https://www.readbyqxmd.com/read/29659717/statin-treatment-is-associated-with-a-neutral-effect-on-health-related-quality-of-life-among-community-dwelling-octogenarian-men
#2
Timo E Strandberg, Annele Urtamo, Juuso Kähärä, Arto Y Strandberg, Kaisu H Pitkälä, Hannu Kautiainen
Background: Statin treatment is common among 80+ people, but little is known about statin effects on health-related quality of life (HRQoL) in this oldest age group. Methods: In the Helsinki Businessmen Study (HBS), men born 1919 to 1934 (original n=3490), have been followed-up since the 1960s. In 2015, a questionnaire about lifestyle, diseases and medications, and including RAND-36/SF-36 HRQoL instrument was mailed to survivors. 612 men (72.6%) responded, 530 of them reporting their medications (98% community-living)...
April 12, 2018: Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
https://www.readbyqxmd.com/read/29656789/voice-signal-characteristics-are-independently-associated-with-coronary-artery-disease
#3
Elad Maor, Jaskanwal D Sara, Diana M Orbelo, Lilach O Lerman, Yoram Levanon, Amir Lerman
OBJECTIVE: Voice signal analysis is an emerging noninvasive diagnostic tool. The current study tested the hypothesis that patient voice signal characteristics are associated with the presence of coronary artery disease (CAD). METHODS: The study population included 138 patients who were enrolled between January 1, 2015, and February 28, 2017: 37 control subjects and 101 subjects who underwent planned coronary angiogram. All subjects had their voice signal recorded to their smartphone 3 times: reading a text, describing a positive emotional experience, and describing a negative emotional experience...
April 12, 2018: Mayo Clinic Proceedings
https://www.readbyqxmd.com/read/29650716/cardiovascular-genetic-risk-testing-for-targeting-statin-therapy-in-the-primary-prevention-of-atherosclerotic-cardiovascular-disease-a-cost-effectiveness-analysis
#4
Jamie Jarmul, Mark J Pletcher, Kristen Hassmiller Lich, Stephanie B Wheeler, Morris Weinberger, Christy L Avery, Daniel E Jonas, Stephanie Earnshaw, Michael Pignone
BACKGROUND: It is unclear whether testing for novel risk factors, such as a cardiovascular genetic risk score (cGRS), improves clinical decision making or health outcomes when used for targeting statin initiation in the primary prevention of atherosclerotic cardiovascular disease (ASCVD). Our objective was to estimate the cost-effectiveness of cGRS testing to inform clinical decision making about statin initiation in individuals with low-to-intermediate (2.5%-7.5%) 10-year predicted risk of ASCVD...
April 2018: Circulation. Cardiovascular Quality and Outcomes
https://www.readbyqxmd.com/read/29643058/a-conceptual-framework-for-addressing-residual-atherosclerotic-cardiovascular-disease-risk-in-the-era-of-precision-medicine
#5
Kershaw V Patel, Ambarish Pandey, James A de Lemos
Until recently, therapies to mitigate atherosclerotic cardiovascular disease (ASCVD) risk have been limited to lifestyle interventions, blood pressure lowering medications, high intensity statin therapy, antiplatelet agents, and in select patients, coronary artery revascularization. Despite administration of these evidence-based therapies, substantial residual risk for cardiovascular events persists, particularly among individuals with known ASCVD. Moreover, the current guideline-based approach does not adequately account for patient-specific, causal pathways that lead to ASCVD progression and complications...
April 11, 2018: Circulation
https://www.readbyqxmd.com/read/29622441/prevalence-of-dyslipidemia-and-achievement-of-low-density-lipoprotein-cholesterol-targets-in-chinese-adults-a-nationally-representative-survey-of-163-641-adults
#6
Mei Zhang, Qian Deng, Linhong Wang, Zhengjing Huang, Maigeng Zhou, Yichong Li, Zhenping Zhao, Yawei Zhang, Limin Wang
BACKGROUND: Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels are established risk factors for cardiovascular diseases, a leading cause of death in China. We sought to assess the latest levels of serum lipids, prevalence of dyslipidemia and achievement of LDL-C lowering targets among Chinese adults. METHODS: Data was obtained from a national representative survey recruited 163,641 adults aged >18years in mainland China between 2013 and 2014...
June 1, 2018: International Journal of Cardiology
https://www.readbyqxmd.com/read/29606189/serum-uric-acid-is-associated-with-the-predicted-risk-of-prevalent-cardiovascular-disease-in-a-community-dwelling-population-without-diabetes
#7
Di Cheng, Rui DU, Xue Yan Wu, Lin Lin, Kui Peng, Li Na Ma, Yu Xu, Min Xu, Yu Hong Chen, Yu Fang Bi, Wei Qing Wang, Meng Dai, Jie Li Lu
OBJECTIVE: To examine the association between serum uric acid levels and cardiovascular disease risk among individuals without diabetes. METHODS: We investigated the association between serum uric acid levels and the risk of prevalent cardiometabolic diseases, 10-year Framingham risk for coronary heart disease, and 10-year risk for atherosclerotic cardiovascular diseases (ASCVD) among 8,252 participants aged ⪖ 40 years without diabetes from Jiading district, Shanghai, China...
February 2018: Biomedical and Environmental Sciences: BES
https://www.readbyqxmd.com/read/29605080/statin-eligibility-in-primary-prevention-from-a-risk-based-strategy-to-a-personalized-approach-based-on-the-predicted-benefit
#8
Fernando H Y Cesena, Antonio G Laurinavicius, Viviane A Valente, Raquel D Conceição, Khurram Nasir, Raul D Santos, Marcio S Bittencourt
Guidelines have recommended statin initiation based on the absolute cardiovascular risk. We tested the hypothesis that a strategy based on the predicted cardiovascular benefit, compared with the risk-based approach, modifies statin eligibility and the estimated benefit in a population in primary cardiovascular prevention. The study included 16,008 subjects (48 ± 6 years, 73% men) with low-density lipoprotein cholesterol levels of 70 to <190 mg/dl, not on lipid-lowering drugs, who underwent a routine health screening in a single center...
March 1, 2018: American Journal of Cardiology
https://www.readbyqxmd.com/read/29601916/b-rca-revealed-circulating-mir-33a-b-associates-with-serum-cholesterol-in-type-2-diabetes-patients-at-high-risk-of-ascvd
#9
Xujing Deng, Shanshan Qin, Yuqi Chen, Huan-Yu Liu, Erfeng Yuan, Haohua Deng, Song-Mei Liu
AIMS: Type 2 diabetes (T2D) is a complex metabolic disease with high incidence throughout the world. Dyslipidemia is the leading cause of atherosclerotic cardiovascular diseases (ASCVD) in T2D patients. hsa-miR-33 (miR-33) serves as a regulator in lipid metabolism. We hypothesized that the blood miR-33 associates with serum lipids in T2D patients at high risk of ASCVD events. METHODS: We developed a branched rolling circle amplification (B-RCA) method and assessed its sensitivity and specificity with mir-33a/b standards by traditional TaqMan assay...
March 27, 2018: Diabetes Research and Clinical Practice
https://www.readbyqxmd.com/read/29589390/high-brachial-ankle-pulse-wave-velocity-as-a-marker-for-predicting-coronary-artery-stenosis-in-patients-with-type-2-diabetes
#10
Bo Hyun Kim, Jae Sik Jang, Yong Seop Kwon, June Hyung Kim, In Joo Kim, Chang Won Lee
BACKGROUND: We evaluated the ability of brachial ankle pulse wave velocity (baPWV) to predict coronary artery stenosis (CAS) in patients with type 2 diabetes, and compared the predictive power of baPWV to that of well-known cardiovascular disease (CVD) risk calculators. METHODS: The study group included 83 consecutive patients over 30 years old with type 2 diabetes who complained of vague chest discomfort. An automatic pulse waveform analyzer was used to measure baPWV...
March 2018: Endocrinology and Metabolism
https://www.readbyqxmd.com/read/29574925/low-density-lipoprotein-cholesterol-lowering-in-individuals-at-intermediate-cardiovascular-risk-percent-reduction-or-target-level
#11
Fernando H Y Cesena, Antonio Gabriele Laurinavicius, Viviane A Valente, Raquel D Conceição, Raul D Santos, Marcio S Bittencourt
BACKGROUND: Recommendations for blood cholesterol management differ across different guidelines. HYPOTHESIS: Lipid-lowering strategies based on low-density lipoprotein-cholesterol (LDL-c) percent reduction or target concentration may have different effects on the expected cardiovascular benefit in intermediate-risk individuals. METHODS: We selected individuals between 40 and 75 years of age with 10-year risk for atherosclerotic cardiovascular disease (ASCVD) between 5...
March 25, 2018: Clinical Cardiology
https://www.readbyqxmd.com/read/29574074/prevalence-management-and-outcomes-of-familial-hypercholesterolemia-in-patients-with-acute-coronary-syndromes-in-the-arabian-gulf
#12
Khalid Al-Rasadi, Ibrahim Al-Zakwani, Alawi A Alsheikh-Ali, Wael Almahmeed, Wafa Rashed, Mustafa Ridha, Raul D Santos, Mohammad Zubaid
BACKGROUND: Information on the epidemiology of familial hypercholesterolemia (FH) in the Arabian Gulf region, which has an elevated rate of consanguinity and type II diabetes, is scarce. OBJECTIVES: To assess the prevalence of FH, its management, and impact on atherosclerotic cardiovascular disease (ASCVD) outcomes in a multicenter cohort of Arabian Gulf patients with acute coronary syndrome (ACS). METHODS: Patients (N = 3224) hospitalized with ACS were studied...
February 14, 2018: Journal of Clinical Lipidology
https://www.readbyqxmd.com/read/29572248/improving-medication-adherence-in-patients-with-cardiovascular-disease-a-systematic-review
#13
REVIEW
Rosemary Hines Fuller, Pablo Perel, Tamara Navarro-Ruan, Robby Nieuwlaat, Robert Brian Haynes, Mark D Huffman
OBJECTIVE: To evaluate and compare the effect of interventions for improving adherence to medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention. METHODS: We extracted eligible trials from a 2014 Cochrane systematic review on adherence for any condition. We updated the search from CENTRAL, Medline, Embase, PsycINFO, CINAHL, Sociological Abstracts and trial registers through November 2016. Study reports needed to be from a randomised controlled trial, incorporate participants identified as having ASCVD and interventions aimed at improving adherence to medicines for secondary prevention of ASCVD and measure both adherence and a clinical outcome...
March 23, 2018: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/29557210/the-emerging-role-of-inflammation-in-cardiovascular-disease
#14
Brandon K Martinez, C Michael White
OBJECTIVE: To review the role of inflammatory suppression in patients with atherosclerotic cardiovascular disease (ASCVD) with a focus on the interleukin-1β blocker canakinumab. DATA SOURCES: An Ovid MEDLINE literature search (1946 to February 2018) was performed using search terms inflammation, ASCVD, atherosclerosis, C-reactive protein, canakinumab. Additional references were identified from a review of literature citations. STUDY SELECTION AND DATA EXTRACTION: English-language studies assessing the impact of pharmacological agents, including canakinumab, on inflammation as measured by high-sensitivity C-reactive protein (hsCRP) and the association with reducing ASCVD events were evaluated...
March 1, 2018: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/29555305/basic-vs-more-complex-definitions-of-family-history-in-the-prediction-of-coronary-heart-disease-the-multi-ethnic-study-of-atherosclerosis
#15
Jaideep Patel, Mahmoud Al Rifai, Maren T Scheuner, Steven Shea, Roger S Blumenthal, Khurram Nasir, Michael J Blaha, John W McEvoy
OBJECTIVE: To determine whether family history of coronary heart disease (FH) definitions differ in their association with atherosclerotic cardiovascular disease (ASCVD) events. PATIENTS AND METHODS: Participants who provided FH data from July 17, 2000, through February 24, 2004, were identified. Definitions of FH were any, premature, and Familial Risk Assessment (FRA). Outcomes included coronary heart disease (CHD), stroke, peripheral artery disease, angina, and congestive heart failure...
March 16, 2018: Mayo Clinic Proceedings
https://www.readbyqxmd.com/read/29550494/elevated-lipoprotein-a-levels-are-associated-with-coronary-artery-calcium-scores-in-asymptomatic-individuals-with-a-family-history-of-premature-atherosclerotic-cardiovascular-disease
#16
Simone L Verweij, Maurice W J de Ronde, Rutger Verbeek, S Matthijs Boekholdt, R Nils Planken, Erik S G Stroes, Sara-Joan Pinto-Sietsma
BACKGROUND: Elevated lipoprotein(a) (Lp(a)) levels are associated with increased risk for atherosclerotic cardiovascular disease (ASCVD). Individuals with a family history of premature ASCVD are at increased cardiovascular risk with concomitantly a higher burden of (subclinical) atherosclerosis. However, whether Lp(a) contributes to the increased atherosclerotic burden in these individuals remains to be established. OBJECTIVE: In this study, we evaluated the association between Lp(a) levels and coronary atherosclerotic burden, assessed by coronary arterty calcium (CAC) scores, in asymptomatic individuals with a family history of premature ASCVD...
February 16, 2018: Journal of Clinical Lipidology
https://www.readbyqxmd.com/read/29536372/contemporary-drug-treatment-of-hypertension-focus-on-recent-guidelines
#17
REVIEW
Wilbert S Aronow, William H Frishman
The 2017 American College of Cardiology/American Heart Association hypertension guidelines diagnose hypertension if systolic blood pressure (SBP) is ≥ 130 mmHg or diastolic blood pressure (DBP) is ≥ 80 mmHg. Increased BP is SBP 120-129 mmHg with DBP < 80 mmHg. Lifestyle measures should be used to treat individuals with increased BP. Lifestyle measures plus BP-lowering drugs should be used for secondary prevention of recurrent cardiovascular events in individuals with clinical cardiovascular disease (coronary heart disease, congestive heart failure, or stroke) and an average SBP ≥ 130 mmHg or an average DBP ≥ 80 mmHg...
April 2018: Drugs
https://www.readbyqxmd.com/read/29535164/glycosylation-profile-of-immunoglobulin-g-is-cross-sectionally-associated-with-cardiovascular-disease-risk-score-and-subclinical-atherosclerosis-in-two-independent-cohorts
#18
Cristina Menni, Ivan Gudelj, Erin MacDonald-Dunlop, Massimo Mangino, Jonas Zierer, Erim Bešić, Peter Joshi, Irena Trbojević-Akmačić, Phil J Chowienczyk, Timothy D Spector, James F Wilson, Gordan Lauc, Ana M Valdes
<u>Rationale:</u> One measure of protein glycosylation (GlycA) has been reported to predict higher cardiovascular risk by reflecting inflammatory pathways <u>Objective:</u> To assess the role of a comprehensive panel of immunoglobulin (IgG) glycosylation traits on traditional risk factors for cardiovascular disease and on presence of subclinical atherosclerosis in addition to GlycA. <u>Methods and Results:</u> We measured 76 IgG glycosylation traits in 2970 women (age range 40-79 years) from the TwinsUK cohort and correlated it to their estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk score and their carotid and femoral plaque measured by ultrasound imaging...
March 13, 2018: Circulation Research
https://www.readbyqxmd.com/read/29525060/usefulness-of-lipoprotein-associated-phospholipase-a-2-activity-and-c-reactive-protein-in-identifying-high-risk-smokers-for-atherosclerotic-cardiovascular-disease-from-the-atherosclerosis-risk-in-communities-study
#19
Martin Tibuakuu, Sina Kianoush, Andrew P DeFilippis, John W McEvoy, Di Zhao, Eliseo Guallar, Christie M Ballantyne, Ron C Hoogeveen, Michael J Blaha, Erin D Michos
Despite the causal role of cigarette smoking in atherosclerotic cardiovascular disease (ASCVD), the underlying mechanisms are not fully understood. We evaluated the joint relation between smoking and inflammatory markers with ASCVD risk. We tested cross-sectional associations of self-reported smoking status (never, former, current) and intensity (packs/day) with lipoprotein-associated phospholipase A2 (Lp-PLA2 ) activity and high-sensitivity C-reactive protein (hsCRP) in 10,506 Atherosclerosis Risk in Communities participants at Visit 4 (1996 to 1998)...
February 6, 2018: American Journal of Cardiology
https://www.readbyqxmd.com/read/29518747/treatment-with-omega-3-polyunsaturated-fatty-acids-does-not-improve-endothelial-function-in-patients-with-type-2-diabetes-and-very-high-cardiovascular-risk-a-randomized-double-blind-placebo-controlled-study-omega-fmd
#20
Aleksander Siniarski, Maciej Haberka, Magdalena Mostowik, Renata Gołębiowska-Wiatrak, Małgorzata Poręba, Krzysztof Piotr Malinowski, Zbigniew Gąsior, Ewa Konduracka, Jadwiga Nessler, Grzegorz Gajos
BACKGROUND AND AIMS: Numerous recent studies conducted in different clinical settings have focused on the benefits of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in the prevention of cardiovascular diseases. There is limited evidence that patients with type 2 diabetes (T2D) and very high cardiovascular risk can also benefit from a high dose of n-3PUFAs, especially those on optimal medical therapy as recommended by the guidelines. The aim of the present study was to assess the impact of high-dose n-3 PUFA treatment on endothelial function in patients with T2D and established atherosclerotic cardiovascular disease (ASCVD)...
March 2, 2018: Atherosclerosis
keyword
keyword
16656
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"